PEPG

PepGen Inc.

17.40 USD
+0.34 (+1.99%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PepGen Inc. stock is up 19.51% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 June’s closed higher than May.

About PepGen Inc.

PepGen Inc. focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy.